Neso 375/20 mg is a dual-action, delayed-release tablet developed by Aristopharma Ltd. It combines Naproxen, a non-steroidal anti-inflammatory drug (NSAID), with Esomeprazole, a proton pump inhibitor (PPI). This formulation is designed to provide effective relief from inflammatory conditions such as arthritis while minimizing the risk of NSAID-induced gastric ulcers